{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T17:04:45Z","timestamp":1775235885930,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["ECCS-1542174"],"award-info":[{"award-number":["ECCS-1542174"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006778","name":"Georgia Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008227","name":"ARCS Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014073","name":"National Nanotechnology Coordinating Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014073","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.nano.2021.102405","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T06:47:03Z","timestamp":1619592423000},"page":"102405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Negatively charged nanoparticles of multiple materials inhibit shear-induced platelet accumulation"],"prefix":"10.1016","volume":"35","author":[{"given":"Michael T.","family":"Griffin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Ashworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaydra","family":"von Behren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.nano.2021.102405_bb0005","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMclde1903004","article-title":"Doctor, should I keep taking an aspirin a day?","volume":"380","author":"Fernandes","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.nano.2021.102405_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ihj.2019.04.001","article-title":"Aspirin for primary prevention: is this the end of the road?","volume":"71","author":"Singal","year":"2019","journal-title":"Indian Heart J"},{"issue":"16","key":"10.1016\/j.nano.2021.102405_bb0015","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.nano.2021.102405_bb0020","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"10152","key":"10.1016\/j.nano.2021.102405_bb0025","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.nano.2021.102405_bb0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00003495-199957030-00015","article-title":"Eptifibatide: a review of its use in patients with acute coronary syndromes and\/or undergoing percutaneous coronary intervention","volume":"57","author":"Goa","year":"1999","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.nano.2021.102405_bb0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9149(00)01427-2","article-title":"Meta-analysis of effectiveness and safety of abciximab versus eptifibatide or tirofiban in percutaneous coronary intervention","volume":"87","author":"Brown","year":"2001","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.nano.2021.102405_bb0040","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"I.I.i.U.A.R.S.U.I.T.T.I., Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","author":"Platelet Glycoprotein","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.nano.2021.102405_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1109719","article-title":"Thrombin-receptor antagonist vorapaxar in acute coronary syndromes","volume":"366","author":"Tricoci","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.nano.2021.102405_bb0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4065\/81.4.518","article-title":"Aspirin and clopidogrel resistance","volume":"81","author":"Michos","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"9038","key":"10.1016\/j.nano.2021.102405_bb0055","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","year":"1996","journal-title":"The Lancet"},{"issue":"9497","key":"10.1016\/j.nano.2021.102405_bb0060","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Group, C.C","year":"2005","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.nano.2021.102405_bb0065","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jvs.2014.12.050","article-title":"Role of high shear rate in thrombosis","volume":"61","author":"Casa","year":"2015","journal-title":"J Vasc Surg"},{"issue":"7","key":"10.1016\/j.nano.2021.102405_bb0070","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/rccm.200110-026OC","article-title":"Ultrafine particles affect experimental thrombosis in an in vivo hamster model","volume":"166","author":"Nemmar","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"1\u20132","key":"10.1016\/j.nano.2021.102405_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1748-0132(08)70014-8","article-title":"Protein-nanoparticle interactions","volume":"3","author":"Lynch","year":"2008","journal-title":"Nano Today"},{"issue":"9","key":"10.1016\/j.nano.2021.102405_bb0080","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1021\/cr100440g","article-title":"Protein-nanoparticle interactions: opportunities and challenges","volume":"111","author":"Mahmoudi","year":"2011","journal-title":"Chem Rev"},{"issue":"4","key":"10.1016\/j.nano.2021.102405_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175871","article-title":"The nanoparticle protein corona formed in human blood or human blood fractions","volume":"12","author":"Lundqvist","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.nano.2021.102405_bb0090","doi-asserted-by":"crossref","DOI":"10.1063\/1.5025349","article-title":"Inhibition of high shear arterial thrombosis by charged nanoparticles","volume":"12","author":"Griffin","year":"2018","journal-title":"Biomicrofluidics"},{"issue":"3","key":"10.1016\/j.nano.2021.102405_bb0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jat.3247","article-title":"Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis","volume":"36","author":"Platel","year":"2016","journal-title":"J Appl Toxicol"},{"issue":"5","key":"10.1016\/j.nano.2021.102405_bb0100","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/0008-5472.CAN-10-3069","article-title":"Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.nano.2021.102405_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s13404-011-0015-8","article-title":"Polyethylene glycol functionalized gold nanoparticles: the influence of capping density on stability in various media","volume":"44","author":"Manson","year":"2011","journal-title":"Gold Bulletin"},{"issue":"5","key":"10.1016\/j.nano.2021.102405_bb0110","doi-asserted-by":"crossref","DOI":"10.1063\/1.5113508","article-title":"Shear-induced platelet aggregation: 3D-grayscale microfluidics for repeatable and localized occlusive thrombosis","volume":"13","author":"Griffin","year":"2019","journal-title":"Biomicrofluidics"},{"issue":"4","key":"10.1016\/j.nano.2021.102405_bb0115","article-title":"Relative contributions of von Willebrand factor and platelets in high shear thrombosis","volume":"4","author":"Casa","year":"2016","journal-title":"Journal of Hematology & Thromboembolic Diseases"},{"key":"10.1016\/j.nano.2021.102405_bb0120","unstructured":"Edelstein, A., et al., Computer control of microscopes using microManager. Curr Protoc Mol Biol, 2010. Chapter 14: p. Unit14 20."},{"issue":"7","key":"10.1016\/j.nano.2021.102405_bb0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCULATIONAHA.117.027290","article-title":"Potent thrombolytic effect of N-acetylcysteine on arterial thrombi","volume":"136","author":"de Lizarrondo","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.nano.2021.102405_bb0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0037-1613739","article-title":"Murine thrombosis models","volume":"92","author":"Day","year":"2004","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.nano.2021.102405_bb0135","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1182\/blood-2015-02-628594","article-title":"Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach","volume":"126","author":"Ciciliano","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.nano.2021.102405_bb0140","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1182\/blood-2005-10-4244","article-title":"Thrombin overcomes the thrombosis defect associated with platelet GPVI\/FcRgamma deficiency","volume":"107","author":"Mangin","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.nano.2021.102405_bb0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vascn.2005.06.006","article-title":"Adaptation of the Folts and electrolytic methods of arterial thrombosis for the study of anti-thrombotic molecules in small animals","volume":"53","author":"Sturgeon","year":"2006","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"7","key":"10.1016\/j.nano.2021.102405_bb0150","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s10439-011-0296-3","article-title":"Rapid platelet accumulation leading to thrombotic occlusion","volume":"39","author":"Para","year":"2011","journal-title":"Ann Biomed Eng"},{"issue":"3","key":"10.1016\/j.nano.2021.102405_bb0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MBC.0000000000000065","article-title":"Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis","volume":"25","author":"Stockschlaeder","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl 1","key":"10.1016\/j.nano.2021.102405_bb0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1538-7836.2011.04320.x","article-title":"Biology and physics of von Willebrand factor concatamers","volume":"9","author":"Springer","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.nano.2021.102405_bb0165","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41467-017-00230-2","article-title":"Flow-induced elongation of von Willebrand factor precedes tension-dependent activation","volume":"8","author":"Fu","year":"2017","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.nano.2021.102405_bb0170","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","article-title":"Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery","volume":"30","author":"Kulkarni","year":"2013","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.nano.2021.102405_bb0175","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpb.2010.12.029","article-title":"Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration","volume":"77","author":"Hirn","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"10.1016\/j.nano.2021.102405_bb0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine (Lond)"},{"issue":"3","key":"10.1016\/j.nano.2021.102405_bb0185","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/mhj.2001.113391","article-title":"Comparative 30-day economic and clinical outcomes of platelet glycoprotein IIb\/IIIa inhibitor use during elective percutaneous coronary intervention: Prairie ReoPro versus Integrilin Cost Evaluation (PRICE) trial","volume":"141","author":"Investigators","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.nano.2021.102405_bb0190","article-title":"Nanoparticle transport in cellular blood flow","author":"Liu","year":"2018","journal-title":"Comput Fluids"},{"key":"10.1016\/j.nano.2021.102405_bb0195","unstructured":"Z Liu, Y.Z., RR Rao, JR Clausen, CK Aidun, Simulating nanoscale suspension of particles and polymers using a coupled lattice-Boltzmann and Langevin-dynamics approach. arXiv preprint, 2018. 1801.02299."},{"issue":"7","key":"10.1016\/j.nano.2021.102405_bb0200","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jmb.2019.02.014","article-title":"Electrostatic steering enables flow-activated Von Willebrand factor to bind platelet glycoprotein, revealed by single-molecule stretching and imaging","volume":"431","author":"Jiang","year":"2019","journal-title":"J Mol Biol"},{"issue":"10","key":"10.1016\/j.nano.2021.102405_bb0205","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nnano.2013.196","article-title":"Nanoparticles: tracking protein corona over time","volume":"8","author":"Lundqvist","year":"2013","journal-title":"Nat Nanotechnol"},{"issue":"38","key":"10.1016\/j.nano.2021.102405_bb0210","doi-asserted-by":"crossref","first-page":"14265","DOI":"10.1073\/pnas.0805135105","article-title":"Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts","volume":"105","author":"Lundqvist","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.nano.2021.102405_bb0215","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"10.1016\/j.nano.2021.102405_bb0220","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0006-291X(92)91769-M","article-title":"Comparison of the primary structure of the functional domains of human and porcine von Willebrand factor that mediate platelet adhesion","volume":"182","author":"Bahnak","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.nano.2021.102405_bb0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/jamaneurol.2014.2886","article-title":"Targeted drug delivery to flow-obstructed blood vessels using mechanically activated nanotherapeutics","volume":"72","author":"Korin","year":"2015","journal-title":"JAMA Neurol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:13:45Z","timestamp":1761549225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963421000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":45,"alternative-id":["S1549963421000484"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102405","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Negatively charged nanoparticles of multiple materials inhibit shear-induced platelet accumulation","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102405"}}